Picture of RTW Biotech Opportunities logo

RTWG — RTW Biotech Opportunities News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedMid CapNeutral

Result of General Meeting

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221219:nRSS1819Ka&default-theme=true

RNS Number : 1819K  RTW Venture Fund Limited  19 December 2022

LEI: 549300Q7EXQQH6KF7Z84

 

19 December 2022

RTW VENTURE FUND LIMITED

 (the "Company")

 

Result of Extraordinary General Meeting

As announced on 1 December 2022, RTW Venture Fund Limited (the "Company") had
convened an extraordinary general meeting (the "Extraordinary General
Meeting") to approve resolutions (the "Resolutions") in connection with the
Company's change of articles of incorporation ("New Articles") and the change
to the Company's tax status, with effect from 1 December 2022, from a
"publicly traded partnership" or "PTP" to a corporation for U.S. federal tax
purposes ("Tax Election").

The Company is pleased to announce that, at the Extraordinary General Meeting
held earlier today, both Resolutions put forward were passed by way of a
poll.  The text of the Resolutions and the votes cast are detailed at the end
of this announcement.

For the purposes of this announcement, unless otherwise defined, capitalised
words and phrases shall have the meaning given to them in the circular to
shareholders dated 1 December 2022 (the "Circular").

 

A copy of the results will be submitted to the National Storage Mechanism and
will be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

For Further Information please contact:

 RTW Investments, LP                               +44 (0) 77 1741 7711
 Woody Stileman, Managing Director

 Buchanan                                          +44 (0)20 7466 5107
 Charles Ryland
 Henry Wilson
 George Beale

 J.P. Morgan Cazenove                              +44 (0)20 7742 4000
 William Simmonds
 Jérémie Birnbaum
 James Bouverat (Sales)

 BofA Securities                                   +44 (0) 20 7628 1000
 Edward Peel
 Kieran Millar

 Elysium Fund Management Limited                   +44 (0) 14 8181 0100
 Joanna Duquemin Nicolle, Chief Executive Officer
 Sadie Morrison, Managing Director

 Morgan Stanley Fund Services USA LLC              +1 (914) 225 8885

 

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused
on identifying transformative assets with high growth potential across the
biopharmaceutical and medical technology sectors. Driven by a long-term
approach to support innovative businesses, RTW Venture Fund invests in
companies developing next-generation therapies and technologies that can
significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading
healthcare-focused entrepreneurial investment firm with deep scientific
expertise and a strong track record of supporting companies developing
life-changing therapies.

Visit the RTW website at www.rtwfunds.com
(https://protect-us.mimecast.com/s/_A8aC5y408fDJXqhzbVHJ?domain=protect.mimecast-offshore.com)
for more information.

 

Resolution 1

 

IT IS HEREBY RESOLVED THAT:

the articles of incorporation produced to the Extraordinary General Meeting
and, for the purposes of identification, initialled by the Chairman (the "New
Articles"), be adopted, with effect from conclusion of the Extraordinary
General Meeting, as the new articles of incorporation of the Company in
substitution for, and to the exclusion, in their entirety, of, the Existing
Articles.

 

 For (including discretionary)  106,003,737 votes (100%)
 Against                        0 votes (0%)
 Withheld*                      2,439 votes

 
 
 

Resolution 2

 

IT IS HEREBY RESOLVED THAT:

the decision of the Board to make the Tax Election be and is hereby ratified.

 

 For (including discretionary)   105,670,734 votes (100%)
 Against                         0 votes (0%)
 Withheld*                       335,442 votes

 

*A vote withheld is not a vote in law and is therefore not counted towards the
proportion of votes "for" or "against" the Resolution. Percentages are
expressed as a proportion of total votes cast (which does not include votes
withheld)

 

Resolution 1 was passed as a special resolution and Resolution 2 was passed as
an ordinary resolution.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMFKLFFLLLFFBX

Recent news on RTW Biotech Opportunities

See all news